Showing results (161-170 of 182) with videos related to

Sort By:
Pageof 19
International Journal of Pharmaceutics|December 10, 2022
Persistent immune response: Twice tumor exfoliation induced by sialic acid-modified vincristine sulfate liposomesXinyang Yan, Xin Gao, Xiaoya Li, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 25, 2023
Helical Anatase Titanium Nanotubes through a Protected Crystallization Strategy for Enhanced Photocatalytic PerformanceXinrong Liu, Mengke Shi, Xiaoyu Tang, et al.
AAPS Pharmscitech|September 14, 2018
Novel Self-Assembled Ibrutinib-Phospholipid Complex for Potently Peroral Delivery of Poorly Soluble Drugs with pH-Dependent SolubilityQiujun Qiu, Mei Lu, Cong Li, et al.
ACS Nano|January 31, 2023
Minimalist Nanocomplex with Dual Regulation of Endothelial Function and Inflammation for Targeted Therapy of Inflammatory Vascular DiseasesShuo Wang, Yuequan Wang, Xiaoxue Lai, et al.
International Journal of Pharmaceutics|March 22, 2022
Neutrophils as emerging immunotherapeutic targets: Indirect treatment of tumors by regulating the tumor immune environment based on a sialic acid derivative-modified nanocomplex platformMeng Chen, Wenjing Wu, Shuo Wang, et al.
Molecular Pharmaceutics|November 6, 2018
Redox- and pH-Sensitive Glycan (Polysialic Acid) Derivatives and F127 Mixed Micelles for Tumor-Targeted Drug DeliveryMingqi Liu, Xiang Luo, Qiujun Qiu, et al.
Drug Delivery|May 24, 2018
Neutrophil-mediated delivery of pixantrone-loaded liposomes decorated with poly(sialic acid)-octadecylamine conjugate for lung cancer treatmentXiang Luo, Ling Hu, Huangliang Zheng, et al.
Biochemical Pharmacology|June 25, 2025
Identification and characterization of a potent peptide inhibitor targeting FOXM1 in cancer therapyAnping Liang, Miao Chang, Zhixian Shang, et al.
Biomaterials|February 26, 2022
Branched PEG-modification: A new strategy for nanocarriers to evade of the accelerated blood clearance phenomenon and enhance anti-tumor efficacyMin Liu, Jie Li, Dan Zhao, et al.
International Journal of Pharmaceutics|October 3, 2020
Targeted delivery of zoledronic acid through the sialic acid - Siglec axis for killing and reversal of M2 phenotypic tumor-associated macrophages - A promising cancer immunotherapyXueying Tang, Dezhi Sui, Mingqi Liu, et al.
Pageof 19